Decibel Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Decibel Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2022.
  • Decibel Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $74.9M, a 31.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $74.9M +$17.9M +31.4% Dec 31, 2022 10-K 2023-03-14
Q4 2021 $57M +$12.7M +28.7% Dec 31, 2021 10-K 2023-03-14
Q4 2020 $44.3M +$10.1M +29.5% Dec 31, 2020 10-K 2023-03-14
Q4 2019 $34.2M Dec 31, 2019 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.